NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Where's NWBO's required documentation of the Advent deal. There are significant requirements for a "related party transaction." .

When a corporation is involved in an acquisition where its CEO also controls the acquired company, there are specific regulatory requirements and obligations to ensure transparency and minimize conflicts of interest. The critical requirements typically involve disclosure, board oversight, and adherence to fiduciary duty principles.

Disclosure Requirements
Such transactions are governed by "related party transaction" rules, which require full disclosure of the CEO's interest and control over both entities in regulatory filings (such as those with the SEC for public companies) if the value involved exceeds certain thresholds—typically transactions exceeding $120,000 must be disclosed.?

The disclosure must identify the related person, detail the relationship, quantify the transaction, describe the terms, and clarify the material interest held by the CEO.?

These disclosures appear in documents such as proxy statements, annual reports, or registration statements and cover the previous fiscal year or up to three years for registration statements.?

Board and Shareholder Approval
Because of the conflict of interest, the board must be proactive in reviewing and approving the transaction, often requiring approval by disinterested directors or even a shareholder vote, especially if the transaction is material.?

Corporate governance dictates that the CEO should recuse themselves from voting or decision-making related to the acquisition due to their dual interest.?

Fiduciary Duty and Self-Dealing Rules
Officers and directors have a fiduciary duty to act in the company’s best interest; self-dealing, where someone benefits personally from such transactions, is generally prohibited unless fully disclosed and managed through independent oversight.?

Regulatory frameworks impose strict rules and possible penalties if the transaction unduly benefits the CEO or is not conducted at arm’s length.

Wonder what the SEC thinks about this deal.